Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 10 Lung Neoplasms 9 Colorectal Neoplasms 7 Breast Neoplasms 7 Prostatic Neoplasms 6 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Stomach Neoplasms 2 Smoking Cessation 2 Neoplastic Cells, Circulating 2 Motor Activity 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Disease 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Stroke 1 Solitary Pulmonary Nodule 1 Skin Neoplasms 1 Sezary Syndrome 1

Interventions

Nivolumab 74 Sunitinib 73 pembrolizumab 49 Everolimus 39 Sorafenib 36 Bevacizumab 36 Axitinib 36 cabozantinib 35 Radiosurgery 33 Ipilimumab 33 pazopanib 32 Magnetic Resonance Spectroscopy 27 Interleukin-2 27 aldesleukin 23 Specimen Handling 22 Cyclophosphamide 21 lenvatinib 20 fludarabine phosphate 17 Radiotherapy 16 Interferon-alpha 15 Peripheral Blood Stem Cell Transplantation 14 Gemcitabine 14 Biopsy 14 temsirolimus 13 Nephrectomy 13 durvalumab 11 Immunohistochemistry 11 CTLA-4 Antigen 11 Blood Specimen Collection 11 Capecitabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Renal Cell × Hematologic Tests × Clear all

NCT04113486 2020-11-24

ENRC

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡